Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 16, 2021 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics to Announce First Quarter 2021 Financial Results on Thursday May 6, 2021

TEMPLE CITY, Calif., April 16, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...
March 15, 2021 16:05 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Awarded Contract from CDC to Study Variants of COVID-19 Virus

TEMPLE CITY, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a technology company providing comprehensive testing solutions...
March 05, 2021 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics to Participate in the Oppenheimer 31st Annual Healthcare Conference

TEMPLE CITY, Calif., March 05, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...
March 04, 2021 16:05 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Reports Record Fourth Quarter and Full Year 2020 Financial Results

Fourth Quarter 2020 Results: Record Revenue of $295.0 million, growing more than 3,400% year-over-yearRecord Billable tests delivered approximately 3.2 million, approximately 230 times the volume of...
February 18, 2021 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics to Announce Fourth Quarter and Full Year 2020 Financial Results on Thursday March 4, 2021

TEMPLE CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...
January 06, 2021 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics to Participate in the H.C. Wainwright BIOCONNECT 2021 Conference

TEMPLE CITY, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...
December 29, 2020 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Extends Partnership with New York City Test and Trace for COVID-19 Testing, Awarded Contract for 2021 School Year

TEMPLE CITY, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (Nasdaq: FLGT), a technology company providing comprehensive testing solutions through its scalable technology platform, today...
November 24, 2020 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics to Participate in the Piper Sandler 32nd Annual Healthcare Conference

TEMPLE CITY, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...
November 23, 2020 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Announces Increase to Full Year 2020 Guidance to $300 million

TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...
November 10, 2020 16:05 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics to Participate in the Credit Suisse 29th Annual Virtual Healthcare Conference

TEMPLE CITY, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...